Royalty Report: Drugs, Cosmetics, Dermatology – Collection: 203516


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Drugs
  • Cosmetics
  • Dermatology
  • Cancer
  • Therapeutic
  • Biotechnology

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 203516

License Grant
Licensor grants to Licensee a right and license, under the Patents and the Know-How, to purchase the Peptides in pure form, at Licensee’s expense, from a manufacturer approved in advance by Licensor in writing; formulate the Peptides into Premix; provided that no Premix may contain more than one Peptide; and market, sell and distribute the Premix to manufacturers in the Market, in each case in the Territory and for commercial purposes only.

The licenses granted herein shall be non-exclusive with respect to Peptide A, and Licensee acknowledges and agrees that Licensor intends to grant the same or similar rights to other parties. The licenses granted herein with respect to Peptide B, Peptide C, Peptide D, Peptide E and Peptide G shall be exclusive.  With respect to Peptide F shall be exclusive with respect to the rights granted only as to the marketing, sales and distribution of Peptide F by Licensee to Rodan+ Fields Dermatologists Inc.

License Property
Patents relate to two anti-aging peptides, palmitoyl-Hexapeptide-6 and Hexapeptide-21.

1. US Patent No. 6,875.744 B2 ('Short Bioactive Peptides')
2. US Patent Application Serial No. l0 /109I 7 1 ('Short Bioactive Peptides and Methods for their Use')
3. US Patent No. 7,354,903 ('Cosmetjc Compositions Containing Short Bioactive Peptides')

The licensed properties are Short Bioactive Peptides.  The different peptides contain different levels of Premix concentrations.  Licensor has developed small, short-chain peptides with anti-infective, anti-inflammatory and modulatory properties such as the stimulation of cell proliferation and migration.  These peptides are targeted for use as ingredients in cosmeceutical products and as new topical therapeutics.

Field of Use
The field of use is dermatology and cosmetics.

IPSCIO Record ID: 357956

License Grant
Licensor grants a non-exclusive right and license, under the Patents and the Know-How, to purchase the Peptides in pure form, at Licensees expense, from Peptisyntha Inc. or another manufacturer approved in advance by Licensor in writing, or from Licensor, subject to availability and on terms as may be agreed between Licensee and Licensor; formulate the Peptides into Premix;  provided that no Premix may contain more than one Peptide; and market, sell and distribute the Premix to manufacturers in the Market, in each case in the Territory and for commercial purposes only.
License Property
Licensor has developed a library of proprietary bioactive peptides. The patents relate to Short Bioactive Peptides and Methods for their Use.
Field of Use
The field of use means the cosmetic and over-the-counter personal-care products market.

Licensee has developed and validated peptide-based and peptide-enhanced ingredient blends for skin care applications targeting improvement in the appearance of acne-prone skin or reduction of visible signs of aging such as lines, wrinkles and loss of firmness and elasticity.

IPSCIO Record ID: 273405

License Grant
Licensor hereby grants Licensee a license under its Proprietary Rights in the Technology. The license is limited to and may be exercised solely for the purposes of (i) performing evaluation and testing of the Peptide to determine suitability as a functional ingredient in Products, including without limitation toxicity and effectiveness tests and trials; (ii) making Products; and (iii) marketing (including selling and offering to sell) Products to distribution customers and end consumers, in each case solely in the Territory. Licensee will not market pure Peptide or sublicense rights hereunder with respect to Peptide, but may sell Products at wholesale to other marketers within the Territory and may combine two or more Peptides into a Product for marketing under this license.  The License Scope is non-exclusive.
License Property
Peptide(s) means Licensor’s proprietary bioactive peptide(s) described below

Name HB64
P-No 64

Patents and Patent Applications
US Patent No. 6,875,744 (Short Bioactive Peptides)
US Patent Application Serial No. 10/109171 (Short Bioactive Peptides and Methods for their Use)
US Patent Application Serial No. 10/839525 (Cosmetic compositions Containing Short Bioactive Peptides)

Product means the final, marketable cosmetic or over-the-counter personal care formulations incorporating Peptide(s) that are set forth below Additional Products may be added by agreement of the parties.

P.A.C. Perfect (Peptide-powered Acne Control) Treatment Essence — Opacified gel containing 1% Salicylic Acid (active ingredient), 0.1% HB64 and other excipient ingredients for treatment of facial acne.
P.A.C. Perfect Treatment Essence may be marketed as part of a set containing the following additional products not containing any Peptide P.A.C. Perfect Toning Cleanser and P.A.C. Perfect nightime Recovery Lotion (the “P.A.C. Perfect Set”).

Technology means inventions (whether or not patentable), ideas, processes, formulas and know-how owned by Licensor as of the date of this Agreement and relating to the Peptides.

Field of Use
This agreement pertains to the drug and personal care industry.

IPSCIO Record ID: 1342

License Grant
Licensor hereby grants to Licensee a personal, non-exclusive license under Licensor's Licensed Trade Secrets and Licensed Patent Rights, including the right to sublicense, to make, have made, use, have used, offer for sale, sell, have sold, or otherwise dispose of the Licensed Peptides for the purpose of making, having made, using, having used, offering for sale, selling, having sold, or otherwise disposing of Licensed Products for the Licensed Field of Use in the Licensed Territory.

Licensed Peptides shall mean the 3 short chain linear peptides, the amino acid sequences.

Licensed Products shall mean any topical, non-pharmaceutical skin care intermediate concentrates and end-use products that contain one or more of the Licensed Peptides.

License Property
The peptides licensed under this Agreement are the 3 short chain linear peptides identified by the amino acid sequences specified below

TPI I.D. Number           Amino Acid Sequence
P 48                             VAKLLAKLAKKLL
P 118                           FAKLLAKALKKFL
P 165                           FALALKALKKL

Field of Use
Licensed Field of Use shall mean the use of  Licensed  Peptides  and  Licensed  Products  in both intermediate concentrates and end-use products for topical, non-pharmaceutical skin care.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.